Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
To assess the duration of severe neutropenia in cycle 1 of chemotherapy after treatment with
a single injection of KRN125 or multiple daily injections of filgrastim.
Phase:
Phase 2
Details
Lead Sponsor:
Kyowa Hakko Kirin Company, Limited Kyowa Kirin Co., Ltd.